Abstract:BackgroundCoronavirus disease 2019 (COVID-19) has been widely spread and caused tens of thousands of deaths, especially in patients with severe COVID-19. This analysis aimed to explore risk factors for mortality of severe COVID-19, and establish a scoring system to predict in-hospital deaths.MethodsPatients with COVID-19 were retrospectively analyzed and clinical characteristics were compared. LASSO regression as well as multivariable analysis were used to screen variables and establish prediction model.FindingsA total of 2529 patients with COVID-19 was retrospectively analyzed, and 452 eligible severe COVID-19 were used for finally analysis. In training cohort, the median age was 66•0 years while it was 73•0 years in non-survivors. Patients aged 60–75 years accounted for the largest proportion of infected populations and mortality toll. Anti-SARS-CoV-2 antibodies were monitored up to 54 days, and IgG levels reached the highest during 20–30 days. No differences were observed of antibody levels between severe and non-severe patients. About 60.2% of severe patients had complications. Among acute myocardial injury (AMI), acute kidney injury (AKI) and acute liver injury (ALI), the heart was the earliest injured organ, whereas the time from AKI to death was the shortest. Age, diabetes, coronary heart disease (CHD), percentage of lymphocytes (LYM%), procalcitonin (PCT), serum urea, C reactive protein and D-dimer (DD), were identified associated with mortality by LASSO binary logistic regression. Then multivariable analysis was performed to conclude that old age, CHD, LYM%, PCT and DD remained independent risk factors for mortality. Based on the above variables, a scoring system of COVID-19 (CSS) was established to divide patients into low-risk and high-risk groups. This model displayed good discrimination (AUC=0·919) and calibration (P=0·264). Complications in low-risk and high-risk groups were significantly different (P<0·05). Use of corticosteroids in low-risk groups increased hospital stays by 4·5 days (P=0·036) and durations of disease by 7·5 days (P=0·012) compared with no corticosteroids.InterpretationOld age, CHD, LYM%, PCT and DD were independently related to mortality. CSS was useful for predicting in-hospital mortality and complications, and it could help clinicians to identify high-risk patients with poor prognosis.FundingThis work was supported by the Key Project for Anti-2019 novel Coronavirus Pneumonia from the Ministry of Science and Technology, China (grant number 2020YFC0845500).

Relationship between ultra-short heart rate variability and short-term mortality in hospitalized COVID-19 patients

Heart rate variability and mortality in critically ill COVID-19 pneumonia patients

Identification of Risk Factors for Mortality Associated with COVID-19

Development and Validation of a Scoring System to Predict the Mortality of Hospitalized Patients with SARS-CoV-2 Omicron: a Nationwide, Multicentre Study

Prognostic Value of Ultra-Short Heart Rate Variability Measures Obtained from Electrocardiogram Recordings of Hospitalized Patients Diagnosed with Non-ST-Elevation Myocardial Infarction

Autonomic Nerve Function Predicts Risk of Early Death after Discharge in Acute Medical Disease

Heart-rate-variability (HRV), predicts outcomes in COVID-19

Development of a Predictive Model for Mortality in Hospitalized Patients With COVID-19

Peer Review #1 of "identification of Risk Factors for Mortality Associated with COVID-19 (V0.1)"

Early Warning Factors of Death in COVID-19 Patients.

Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study

Scores Based on Neutrophil Percentage and Lactate Dehydrogenase with or Without Oxygen Saturation Predict Hospital Mortality Risk in Severe COVID-19 Patients

Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA

A model to predict the risk of mortality in severely ill COVID-19 patients

Scoring Systems for Predicting Mortality for Severe Patients with COVID-19

Scores based on neutrophil percentage and lactate dehydrogenase with or without oxygen saturation predict the risk of hospital mortality in severe COVID-19 patients

Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study

Mortality Risk Analysis for Patients with Severe Coronavirus Disease 2019 Pneumonia

Development and validation of a prediction model for mortality in critically ill COVID-19 patients

Prognostic Values of Heart Rate Variations and Their Predictions on Outcomes in Critical Severe Cases

Early Prediction of Mortality Risk among Patients with Severe COVID-19, Using Machine Learning